中国当代医药2024,Vol.31Issue(13) :19-23.

五灵胶囊联合替诺福韦治疗乙型肝炎肝硬化的临床疗效及作用机制

Clinical effect and mechanism of Wuling Capsules combined with Tenofovir in the treatment of hepatitis B cirrhosis

盛反修 夏金荣 卢仁
中国当代医药2024,Vol.31Issue(13) :19-23.

五灵胶囊联合替诺福韦治疗乙型肝炎肝硬化的临床疗效及作用机制

Clinical effect and mechanism of Wuling Capsules combined with Tenofovir in the treatment of hepatitis B cirrhosis

盛反修 1夏金荣 1卢仁2
扫码查看

作者信息

  • 1. 江西省上饶市第二人民医院肝病科,江西上饶 334000
  • 2. 江西省上饶技术职业学院社区护理,江西上饶 334000
  • 折叠

摘要

目的 探究五灵胶囊联合替诺福韦治疗乙型肝炎肝硬化的临床疗效及作用机制.方法 选取2022年1月至2023年3月上饶市第二人民医院诊治的64例乙型肝炎肝硬化患者作为研究对象,采用随机数字表法将其分为对照组与观察组,各32例.对照组施行替诺福韦治疗,观察组施行五灵胶囊联合替诺福韦治疗.比较两组患者临床疗效、肝功能以及肝纤维化指标,观察两组患者免疫功能与炎症因子水平.结果 观察组总有效率(96.87%)高于对照组(81.25%),差异有统计学意义(P<0.05);观察组治疗6个月后的丙氨酸氨基转移酶、天门冬氨酸氨基转氨酶及总胆红素含量均小于对照组,差异有统计学意义(P<0.05);观察组治疗6个月后血清透明质酸、层粘连蛋白及Ⅲ型前胶原水平均低于对照组,差异有统计学意义(P<0.05);观察组治疗6个月后成熟的T淋巴细胞(CD3+)、CD4+T淋巴细胞(CD4+)、CD4+/CD8+水平均高于对照组,差异有统计学意义(P<0.05);观察组治疗6个月后血清中血清肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)及生长转化因子(TGF-β1)均少于对照组,差异有统计学意义(P<0.05).结论 五灵胶囊联合替诺福韦治疗乙型肝炎肝硬化,效果良好,可有效改善肝功能,减缓肝硬化,降低肝损伤,提高免疫力,缓解炎症反应.

Abstract

Objective To investigate the clinical effect and mechanism of Wuling Capsules combined with Tenofovir in the treatment of hepatitis B cirrhosis.Methods A total of 64 patients with hepatitis B cirrhosis who were diagnosed and treated in Shangrao Second People's Hospital from January 2022 to March 2023 were selected as the study subjects.They were divided into the control group and the observation group using the random number table method,with 32 patients in each group.The control group was treated with Tenofovir,and the observation group was treated with Wuling Capsules combined with Tenofovir.The two groups were compared in terms of clinical efficacy,liver function and liver fibrosis indicators.Immune function and levels of inflammatory factors in the two groups were observed.Results The total effective rate in the observation group(96.87%)was higher than that in the control group(81.25%),and the difference was statistically significant(P<0.05).After 6 months of treatment,the levels of alanine aminotransferase,aspartate aminotransferase,total bilirubin,serum hyaluronic acid,laminin and type Ⅲ procollagen in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).After 6 months of treatment,the levels of CD3+.CD4+and CD4+/CD8+in the observation group were higher than those in the control group,and the differences were statistically significant(P<0.05).After 6 months of treatment,serum tumor necrosis factor-α(TNF-α),interleukin 6(IL-6)and transforming growth factor-β1(TGF-β1)levels in observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).Conclusion Wuling Capsules combined with Tenofovir is effective in the treatment of hepatitis B cirrhosis,which can effectively improve liver function,relieve cirrhosis,reduce liver damage,enhance immunity and alleviate inflammatory reactions.

关键词

五灵胶囊/替诺福韦/乙型肝炎肝硬化/肝功能/疗效

Key words

Wuling Capsules/Tenofovir/Hepatitis B cirrhosis/Liver function/Curative effect

引用本文复制引用

基金项目

江西省中医药局科技项目(2023A0260)

出版年

2024
中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
参考文献量23
段落导航相关论文